Dr. Frazier is a licensed clinical psychologist who received his Ph.D. from Case Western Reserve University in 2004. He joined Cleveland Clinic in 2006 and from 2013-2017 was the director of the Cleveland Clinic Center for Autism. Over the last decade, Dr. Frazier's research has focused on two areas: 1) using remote eye gaze tracking to improve early identification of autism, and 2) translational studies of the sub-group of autism associated with PTEN mutations. Over the last 3 years, he has published the first studies identifying remote eye tracking measures as predictive of autism risk and symptom levels and the first comprehensive characterization of patients with autism and PTEN mutations. Dr. Frazier joined Autism Speaks in April 2017 as Chief Science Officer.